Synthetic Antigen-Presenting Cells for Adoptive T Cell Therapy.
Ontology highlight
ABSTRACT: Adoptive T cell therapies are transforming the treatment of solid and liquid tumors, yet their widespread adoption is limited in part by the challenge of generating functional cells. T cell activation and expansion using conventional antigen-presenting cells (APCs) is unreliable due to the variable quality of donor-derived APCs. As a result, engineered approaches using nanomaterials presenting T cell activation signals are a promising alternative due to their ability to be robustly manufactured with precise control over stimulation cues. In this work, we design synthetic APCs that consist of liposomes surface-functionalized with peptide-major histocompatibility complexes (pMHC). Synthetic APCs selectively target and activate antigen-specific T cell populations to levels similar to conventi
SUBMITTER: Dahotre SN
PROVIDER: S-EPMC8447293 | biostudies-literature | 2021 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA